| Global burden of primary liver cancer in 2020 and predictions to 2040 H Rumgay, M Arnold, J Ferlay, O Lesi, CJ Cabasag, J Vignat, ... Journal of hepatology 77 (6), 1598-1606, 2022 | 582 | 2022 |
| Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN E Morgan, M Arnold, A Gini, V Lorenzoni, CJ Cabasag, M Laversanne, ... Gut 72 (2), 338-344, 2023 | 453 | 2023 |
| Changes in colorectal cancer incidence in seven high-income countries: a population-based study M Araghi, I Soerjomataram, A Bardot, J Ferlay, CJ Cabasag, DS Morrison, ... The lancet Gastroenterology & hepatology 4 (7), 511-518, 2019 | 368 | 2019 |
| Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020 CJ Cabasag, PJ Fagan, J Ferlay, J Vignat, M Laversanne, L Liu, ... International Journal of Cancer 151 (9), 1535-1541, 2022 | 110 | 2022 |
| Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project) M Araghi, M Arnold, MJ Rutherford, MG Guren, CJ Cabasag, A Bardot, ... Gut 70 (1), 114-126, 2021 | 97 | 2021 |
| Cervical cancer burden in Latin America and the Caribbean: Where are we? S Pilleron, CJ Cabasag, J Ferlay, F Bray, S Luciani, M Almonte, M Piñeros International journal of cancer 147 (6), 1638-1648, 2020 | 72 | 2020 |
| Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry L Quan, Z Gong, S Yao, EV Bandera, G Zirpoli, H Hwang, M Roberts, ... International journal of cancer 134 (6), 1408-1421, 2014 | 61 | 2014 |
| The influence of birth cohort and calendar period on global trends in ovarian cancer incidence CJ Cabasag, M Arnold, J Butler, M Inoue, B Trabert, PM Webb, F Bray, ... International journal of cancer 146 (3), 749-758, 2020 | 56 | 2020 |
| Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a … Q Luo, DL O’Connell, XQ Yu, C Kahn, M Caruana, F Pesola, P Sasieni, ... The Lancet Public Health 7 (6), e537-e548, 2022 | 52 | 2022 |
| Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis P Sarich, CJ Cabasag, E Liebermann, P Vaneckova, C Carle, S Hughes, ... EClinicalMedicine 47, 2022 | 42 | 2022 |
| Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study CJ Cabasag, J Butler, M Arnold, M Rutherford, A Bardot, J Ferlay, ... Gynecologic oncology 157 (1), 234-244, 2020 | 36 | 2020 |
| Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women’s Circle of Health Study (WCHS) Z Gong, L Quan, S Yao, G Zirpoli, EV Bandera, M Roberts, JG Coignet, ... PloS one 8 (8), e72619, 2013 | 33 | 2013 |
| Impact of COVID-19 pandemic on cancer-related hospitalizations in Brazil A Mafra da Costa, AL Ribeiro, AG Ribeiro, A Gini, C Cabasag, RM Reis, ... Cancer Control 28, 10732748211038736, 2021 | 27 | 2021 |
| Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care CH Norell, J Butler, R Farrell, A Altman, J Bentley, CJ Cabasag, ... International Journal of Gynecologic Cancer 30 (11), 2020 | 27 | 2020 |
| Pancreatic cancer: an increasing global public health concern CJ Cabasag, J Ferlay, M Laversanne, J Vignat, A Weber, I Soerjomataram, ... Gut 71 (8), 1686-1687, 2022 | 26 | 2022 |
| Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries I Soerjomataram, C Cabasag, A Bardot, MM Fidler-Benaoudia, ... The Lancet Oncology 24 (1), 22-32, 2023 | 24 | 2023 |
| Population‐based cancer staging for oesophageal, gastric, and pancreatic cancer 2012‐2014: International Cancer Benchmarking Partnership SurvMark‐2 CJ Cabasag, M Arnold, M Piñeros, E Morgan, J Brierley, J Hofferkamp, ... International Journal of Cancer 149 (6), 1239-1246, 2021 | 11 | 2021 |
| Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): A population-based study CJ Cabasag, M Arnold, M Rutherford, A Bardot, J Ferlay, E Morgan, ... British Journal of Cancer 126 (12), 1774-1782, 2022 | 10 | 2022 |
| The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020 CJ Cabasag, J Vignat, J Ferlay, V Arndt, V Lemmens, J Praagman, F Bray, ... European Journal of Cancer 177, 15-24, 2022 | 9 | 2022 |
| Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research S Virani, G Baiocchi, D Bowtell, CJ Cabasag, KR Cho, RT Fortner, ... Carcinogenesis 42 (6), 785-793, 2021 | 9 | 2021 |
Eileen MorganInternational Agency for Research on Cancer
Eileen MorganInternational Agency for Research on Cancer